Integra LifeSciences Holdings Corporation Revenue 2016–2025
Integra LifeSciences Holdings Corporation annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Integra LifeSciences Holdings Corporation revenue for the quarter ending March 31, 2026 was 391.9 M, a 2.42% increase year-over-year.
- Integra LifeSciences Holdings Corporation revenue for the twelve months ending March 31, 2026 was 1.6 B, a 2.71% increase year-over-year.
- Integra LifeSciences Holdings Corporation annual revenue for 2025 was 1.6 B, a 1.53% increase from 2024.
- Integra LifeSciences Holdings Corporation annual revenue for 2024 was 1.6 B, a 4.47% increase from 2023.
- Integra LifeSciences Holdings Corporation annual revenue for 2023 was 1.5 B, a 1.03% decrease from 2022.
- Integra LifeSciences Holdings Corporation annual revenue for 2022 was 1.6 B.
Integra LifeSciences Holdings Corporation (IART) — Frequently Asked Questions
Integra LifeSciences Holdings Corporation (IART) is a publicly traded US company. It has a market capitalization of $1.31B. In fiscal 2025 it reported revenue of $1.64B and net income of -$516M. Explore IART's stock price, financial statements, earnings history, margins and key ratios below.
What is Integra LifeSciences Holdings Corporation's market cap?
Integra LifeSciences Holdings Corporation (IART) has a market capitalization of $1.31B.
What is the IART stock price?
IART trades at $17.09 (-4.53% on the day).
How much revenue does Integra LifeSciences Holdings Corporation make?
Integra LifeSciences Holdings Corporation reported revenue of $1.64B in fiscal 2025.
Is IART profitable?
In fiscal 2025, Integra LifeSciences Holdings Corporation reported net income of -$516M.